Combination chemotherapy versus melphalan plus prednisone as treatment for multiple myeloma: An overview of 6,633 patients from 27 randomized trials

Combination chemotherapy versus melphalan plus prednisone as treatment for multiple myeloma: An overview of 6,633 patients from 27 randomized trials

Bibliographic Details
Main Authors:	Pasquali, S, Maqueo, J, Vela, J, Kyle, R, Leong, T, Fritz, E, Suciu, S, Palva, I, Oivanen, T, Corrado, C, Lastiri, F, Peest, D, Kildahl-Andersen, O, Maniatis, A, Alison, R, Clarke, M, Evans, V, Gray, R, Greaves, E, Hall, E, Hicks, C, James, S, Peto, R, Richards, S, Sinclair, D
Format:	Journal article
Published:	1998

Similar Items

Bortezomib (velcade) plus melphalan and prednisone in elderly untreated patients with multiple myeloma
by: S. S. Bessmeltsev, et al.
Published: (2022-11-01)

A complex case of necrobiotic xanthogranuloma with IgG‐kappa paraproteinemia: Disease regression achieved with melphalan and prednisone combination therapy
by: Jacques A. J. Malherbe, et al.
Published: (2022-11-01)

S300: HEALTH-RELATED QUALITY OF LIFE IN TRANSPLANT-INELIGIBLE REAL-LIFE MULTIPLE MYELOMA PATIENTS TREATED WITH BORTEZOMIB-MELPHALAN-PREDNISONE (VMP) VS. LENALIDOMIDE-DEXAMETHASONE (RD)
by: M. D’Agostino, et al.
Published: (2022-06-01)

P12 HEALTH-RELATED QUALITY OF LIFE IN FRAIL AND INTERMEDIATE-FIT PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA TREATED WITH DOSE-ADJUSTED MELPHALAN-PREDNISONE-BORTEZOMIB (MPV)
by: M.R. Seefat, et al.
Published: (2023-05-01)

P07 BORTEZOMIB-MELPHALAN-PREDNISONE (VMP) VS. LENALIDOMIDE-DEXAMETHASONE (RD) IN REAL-LIFE MULTIPLE MYELOMA PATIENTS INELIGIBLE FOR TRANSPLANT: UPDATED ANALYSIS OF THE RANDOMIZED PHASE IV REAL MM TRIAL
by: A. Larocca, et al.
Published: (2023-05-01)

Calculation of Mode Properties for Single-Mode and Multimode Fibers at 633 nm
by: Wasan M. Hmood, et al.
Published: (2022-10-01)

Clinicopathologic and gastrointestinal effects of administration of prednisone, prednisone with omeprazole, or prednisone with probiotics to dogs: A double‐blind randomized trial
by: Mariola B. Rak, et al.
Published: (2023-03-01)

P1680: HEALTH-RELATED QUALITY OF LIFE IN TRANSPLANT-INELIGIBLE REAL-LIFE MULTIPLE MYELOMA PATIENTS TREATED WITH FIXED-DURATION BORTEZOMIB-MELPHALAN-PREDNISONE VS. CONTINUOUS LENALIDOMIDE-DEXAMETHASONE
by: Mattia D’agostino, et al.
Published: (2023-08-01)

Melphalan intra-arterial chemotherapy for choroidal melanoma chemoreduction
by: Rodrigo Jorge, et al.
Published: (2022-08-01)

الفتح الإسلامی للحیرة عام 12هـ/633م
by: صالح حسن
Published: (2009-08-01)

Encephalopathy complicating high-dose melphalan.
by: Schuh, A, et al.
Published: (1999)

Mycosubtilin Produced by <i>Bacillus subtilis</i> ATCC6633 Inhibits Growth and Mycotoxin Biosynthesis of <i>Fusarium graminearum</i> and <i>Fusarium verticillioides</i>
by: Chenjie Yu, et al.
Published: (2021-11-01)

Efficacy and Safety of High-Dose Chemotherapy with Treosulfan and Melphalan in Multiple Myeloma
by: Cédric Gillich, et al.
Published: (2023-05-01)

Unsupervised learning to understand patterns of comorbidity in 633,330 patients diagnosed with osteoarthritis
by: Pineda Moncusi, M, et al.
Published: (2022)

P633: Social determinants of health and genetic testing in intrauterine fetal demise
by: April Adams, et al.
Published: (2023-01-01)

Prednisone-dependent asthma: inflammatory indices in induced sputum.
by: Pizzichini, M, et al.
Published: (1999)

The Combination of Panobinostat and Melphalan for the Treatment of Patients with Multiple Myeloma
by: Maria Gkotzamanidou, et al.
Published: (2022-12-01)

Efficacy and safety of ultra-low dose inhaled melphalan in the treatment of hospitalized patients with COVID-19
by: E. A. Sinitsyn, et al.
Published: (2022-05-01)

Gene Set Subtraction Reveals 633 Candidate Genes for Bamboo Culm Wall Thickening
by: Yaping Hu, et al.
Published: (2020-12-01)

Inhibition of carbonic anhydrase activity modifies the toxicity of doxorubicin and melphalan in tumour cells in vitro.
by: Gieling, R, et al.
Published: (2013)

Isolated chemohyperthermal perfusion of the liver with melphalan in the treatment of unresectable liver metastases with uveal melanoma
by: A. D. Kaprin, et al.
Published: (2021-12-01)

Optimising prednisolone or prednisone replacement in adrenal insufficiency
by: Angelica Sharma, et al.
Published: (2023-07-01)

Treatment of haemophagocytic lymphohistiocytosis with cyclophosphamide, vincristine and prednisone
by: Yixin Hu, et al.
Published: (2012-01-01)

Classification of patients with osteoarthritis through clusters of comorbidities using 633,330 individuals from Spain
by: Pineda Moncusi, M, et al.
Published: (2023)

A GPS-Referenced Wavelength Standard for High-Precision Displacement Interferometry at λ = 633 nm
by: Ulrike Blumröder, et al.
Published: (2023-02-01)

Efficiency of lenalidomide, bortezomib and prednisone (RVP) in patients with newly diagnosed multiple myeloma
by: K. A. Belousov, et al.
Published: (2019-04-01)

Synthesis and In Vitro Activity of Novel Melphalan Analogs in Hematological Malignancy Cells
by: Anastazja Poczta, et al.
Published: (2022-02-01)

MELPHALAN-INDUCED CYTOTOXICITY IN THE BONE MARROW OF RATS BY FLOW CYTOMETRY MEASUREMENTS
by: B I. Gerashchenko, et al.
Published: (2019-03-01)

Isolated Limb Perfusion With Melphalan Triggers Immune Activation in Melanoma Patients
by: Junko Johansson, et al.
Published: (2018-12-01)

Perception and usage of short-term prednisone and prednisolone in dogs
by: Margaret Gober, et al.
Published: (2023-07-01)

Private pilgrimages at Syon Abbey? A note on Cambridge University Library MS Ff.6.33
by: Lucas, H
Published: (2019)

Characterization of the far-red fluorescent probe MitoView 633 for dynamic mitochondrial membrane potential measurement
by: Patrick Ernst, et al.
Published: (2023-10-01)

“Hebrew, beloved of God”: the Adamic language in the thought of Jacob, Bishop of Edessa (c. 633–708 CE)
by: Salvesen, AG
Published: (2022)

Enhancing Prednisone-Based Arthritis Therapy with Targeted IL-27 Gene Delivery
by: Adriana A. Marin, et al.
Published: (2022-06-01)

Phosphatidylinositol Stabilizes Fluid-Phase Liposomes Loaded with a Melphalan Lipophilic Prodrug
by: Daria Tretiakova, et al.
Published: (2021-04-01)

Hybrid Molecules of Benzylguanidine and the Alkylating Group of Melphalan: Synthesis and Effects on Neuroblastoma Cells
by: Gernot Bruchelt, et al.
Published: (2023-07-01)

Ocular Survival Following Intravitreal Melphalan as Adjuvant Treatment for Vitreous Retinoblastoma Seeding
by: Alahmadi G, et al.
Published: (2023-06-01)

Antioxidant Defenses Confer Resistance to High Dose Melphalan in Multiple Myeloma Cells
by: Claire Gourzones, et al.
Published: (2019-03-01)

BeEAM (Bendamustine, Etoposide, Cytarabine, Melphalan) Versus BEAM (Carmustine, Etoposide, Cytarabine, Melphalan) as Conditioning Regimen Before Autologous Haematopoietic Cell Transplantation: A Systematic Review and Meta-Analysis
by: Ran Wu, et al.
Published: (2023-06-01)

EFFECTS OF IMIDOPYRAN AND PREDNISONE IN THE TREATMENT OF BABESIOSIOSIS-ASSOCIATED ANEMIA IN DOGS
by: NEVIDNYK-PRAVDA A.Y.
Published: (2023-04-01)